QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NASDAQ:ICCM

IceCure Medical - ICCM Stock Forecast, Price & News

$1.10
+0.01 (+0.91%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.09
$1.13
50-Day Range
$1.05
$1.49
52-Week Range
$0.75
$4.73
Volume
60,623 shs
Average Volume
279,456 shs
Market Capitalization
$50.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.38

IceCure Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
295.9% Upside
$4.38 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of IceCure Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.44) to ($0.33) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

851st out of 986 stocks

Surgical & Medical Instruments Industry

86th out of 100 stocks


ICCM stock logo

About IceCure Medical (NASDAQ:ICCM) Stock

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
7 Speculative Penny Stocks to Bet On This March
ICCM IceCure Medical Ltd
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
IceCure Medical Ltd. Announces Proposed Public Offering
What Is Going on With IceCure Medical (ICCM) Stock Today?
See More Headlines
Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Company Calendar

Today
3/23/2023
Next Earnings (Confirmed)
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ICCM
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.38
High Stock Price Forecast
$5.75
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+294.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-9,900,000.00
Net Margins
-462.46%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.14 million

Miscellaneous

Free Float
44,510,000
Market Cap
$50.64 million
Optionable
Not Optionable
Beta
-0.25

Key Executives

  • Mr. Eyal Shamir (Age 62)
    CEO & Director
    Comp: $426k
  • Mr. Ronen Tsimerman CPA (Age 54)
    CFO & COO
    Comp: $324k
  • Ms. Tlalit Bussi Tel-Tzure (Age 52)
    VP of Bus. Devel. & Global Marketing
    Comp: $249k
  • Ms. Merav Nir Dotan (Age 54)
    VP of HR
    Comp: $32k
  • Mr. Naum Muchnik (Age 47)
    VP of Research, Devel. & Engineering
    Comp: $238k
  • Mr. Shay Levav (Age 46)
    VP of Regulatory and Quality Assurance & Clinical Applications
    Comp: $239k













ICCM Stock - Frequently Asked Questions

Should I buy or sell IceCure Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares.
View ICCM analyst ratings
or view top-rated stocks.

What is IceCure Medical's stock price forecast for 2023?

3 equities research analysts have issued twelve-month price targets for IceCure Medical's stock. Their ICCM share price forecasts range from $3.00 to $5.75. On average, they predict the company's share price to reach $4.38 in the next twelve months. This suggests a possible upside of 294.1% from the stock's current price.
View analysts price targets for ICCM
or view top-rated stocks among Wall Street analysts.

How have ICCM shares performed in 2023?

IceCure Medical's stock was trading at $1.55 at the start of the year. Since then, ICCM stock has decreased by 28.4% and is now trading at $1.11.
View the best growth stocks for 2023 here
.

When is IceCure Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our ICCM earnings forecast
.

How can I listen to IceCure Medical's earnings call?

IceCure Medical will be holding an earnings conference call on Wednesday, March 29th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has IceCure Medical issued on next quarter's earnings?

IceCure Medical updated its FY 2022 earnings guidance on Thursday, February, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.10 million-$3.10 million, compared to the consensus revenue estimate of $3.59 million.

What is IceCure Medical's stock symbol?

IceCure Medical trades on the NASDAQ under the ticker symbol "ICCM."

Who are IceCure Medical's major shareholders?

IceCure Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Bank of America Corp DE (0.12%), Boothbay Fund Management LLC (0.09%) and UBS Group AG (0.06%).

How do I buy shares of IceCure Medical?

Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IceCure Medical's stock price today?

One share of ICCM stock can currently be purchased for approximately $1.11.

How much money does IceCure Medical make?

IceCure Medical (NASDAQ:ICCM) has a market capitalization of $50.64 million and generates $4.14 million in revenue each year. The company earns $-9,900,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How can I contact IceCure Medical?

The official website for the company is www.icecure-medical.com. The company can be reached via phone at 972-4623-0333, via email at jeremy@lifesciadvisors.com, or via fax at 972-4623-0222.

This page (NASDAQ:ICCM) was last updated on 3/23/2023 by MarketBeat.com Staff